Profile
Peter K.
Working was Senior Vice President of Research and Development for Cell Genesys, Inc., which he joined in September 2001.
Prior to joining Cell Genesys, he served as Vice President of Analytical and Non-Clinical Sciences and Principal Scientist at ALZA Corporation from 1999 to 2001.
From 1992 to 1999, Dr. Working was employed by SEQUUS Pharmaceuticals, where he was Vice President of Research and Development.
From 1988 to 1992, he was employed by Genentech, Inc., where he served as a Senior Toxicologist and Head of the Experimental Toxicology Group in the Department of Safety Evaluation.
Dr. Working received PhD, MS and BS degrees from the University of California at Davis and an MA from the University of California, San Francisco.
Former positions of Peter K. Working
| Companies | Position | End |
|---|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Chief Tech/Sci/R&D Officer | 2008-10-29 |
| ALZA CORPORATION | Corporate Officer/Principal | 2000-12-31 |
SEQUUS Pharmaceuticals, Inc.
SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases | Chief Tech/Sci/R&D Officer | 1998-12-31 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 1991-12-31 |
Training of Peter K. Working
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
SEQUUS Pharmaceuticals, Inc.
SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases | Health Technology |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Peter K. Working
















